Diphenyl diazole derivative, and preparation method and application thereof
A technology of biphenyldiazoles and azole derivatives, which is applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, organic active ingredients, etc., and can solve problems such as narrow antibacterial spectrum, drug resistance, and drug interactions. Achieve good antifungal and antibacterial activity, strong antibacterial activity, and good application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] Example 1 N-[1-(1H-imidazol-1-yl)-3-(1H-imidazol-4-yl)prop-2-yl]-(1,1'-biphenyl)-4-carboxamide.
[0057]
[0058] Step 1 Preparation of 1,1'-biphenylcarboxylic acid (intermediate 3).
[0059] Under argon protection, 2.75g (13.8mmol) of 4-bromobenzoic acid, 2g (16.4mmol) of phenylboronic acid, K 2 CO 3 2.71g (27.3mmol) and 0.2g tetrakistriphenylphosphopalladium were added to 40mL of dioxane solvent / water (10:1), and the temperature was raised to 75°C. After 5h, the reaction was monitored by TLC. The reaction solution was cooled, filtered with suction, and the pH value was adjusted to 2-3. A large amount of white solid was formed, and 2.30 g of white solid was obtained by suction filtration, with a yield of 84.9%. MS[M+H] + (m / z): 199.2.
[0060] Step 2 Preparation of intermediate 5.
[0061] Intermediate 3 (2g, 10.1mmol), EDC·HCl 2.13g (11.1mmol) and HOBt 1.50g (11.1mmol) were dissolved in 40mL DMF, stirred at room temperature for 1h, and histidinol hydrochloride...
Embodiment 2
[0066] Example 2 N-[1-(1H-imidazol-1 base)-3-(1H-imidazol-4 base)prop-2-yl]-2'-fluoro-(1,1'-biphenyl)- 4-formamide
[0067]
[0068] LC-MS m / z[M+H] + 390.2. 1 H-NMR (600MHz, DMSO-d 6 )δ13.24(s,1H),9.04(d,J=8.0Hz,1H),8.76(s,1H),7.90(d,J=8.4Hz,2H),7.80(s,1H),7.68– 7.65(m,2H),7.63(s,1H),7.60(td,J=7.9,1.5Hz,1H),7.51–7.43(m,1H),7.36–7.33(m,2H),7.23(s, 1H), 6.87(s, 1H), 4.88(ddd, J=9.9, 8.1, 4.7Hz, 1H), 4.57(dd, J=14.1, 4.7Hz, 1H), 4.42(dd, J=14.1, 10.0Hz ,1H),2.96-2.63(m,2H).
Embodiment 3
[0069] Example 3 N-[1-(1H-imidazol-1 base)-3-(1H-imidazol-4 base)prop-2-yl]-2'-chloro-(1,1'-biphenyl)- 4-formamide
[0070]
[0071] LC-MS m / z[M+H] + 406.2. 1 H-NMR (400MHz, DMSO-d 6 )δ13.15(s, 1H), 9.01(d, J=7.9Hz, 1H), 8.74(s, 1H), 7.85(d, J=8.3Hz, 2H), 7.76(s, 1H), 7.64( s,1H),7.62–7.58(m,1H),7.55(d,J=8.4Hz,2H),7.49–7.41(m,3H),7.23(s,1H),6.86(s,1H),5.02 –4.90(m,1H),4.79–4.74(m,1H),4.41(dd,J=14.0,9.9Hz,1H),2.95-2.64(m,2H).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



